"HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, ranked No. 1 in orthopedics for 12 years in a row by U.S. News & World Report (2021-2022). HSS has also been among the top-ranked hospitals for both orthopedics and rheumatology for 30 consecutive years."

During the past decade, Hospital for Special Surgery conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 120 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 84 clinical trials started and 63 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital for Special Surgery" #1 sponsor was "Hospital for Special Surgery, New York" with 169 trials, followed by "Smith & Nephew, Inc." with 8 trials sponsored, "Cytokinetics" with 5 trials sponsored, "Endo Pharmaceuticals" with 5 trials sponsored and "International Spine Study Group Foundation" with 5 trials sponsored. Other sponsors include 167 different institutions and companies that sponsored additional 134 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital for Special Surgery" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 17 trials as a collaborator, "Hospital for Special Surgery, New York" with 15 trials as a collaborator, "The Cleveland Clinic" with 6 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator and "The Hospital for Sick Children" with 5 trials as a collaborator. Other collaborators include 241 different institutions and companies that were collaborators in the rest 172 trials.

According to Clinical.Site data, the most researched conditions in "Hospital for Special Surgery" are "Amyotrophic Lateral Sclerosis" (15 trials), "Osteoarthritis" (14 trials), "Osteoarthritis, Knee" (14 trials), "Systemic Lupus Erythematosus" (12 trials) and "Knee Osteoarthritis" (10 trials). Many other conditions were trialed in "Hospital for Special Surgery" in a lesser frequency.

Most popular intervention types in "Hospital for Special Surgery" are "Drug" (151 trials), "Device" (83 trials), "Other" (70 trials), "Procedure" (63 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Bupivacaine" (7 trials), "Dexamethasone" (7 trials), "Abatacept" (5 trials) and "Prednisone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital for Special Surgery" are 357 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital for Special Surgery". undefined are not yet recruiting, 72 are recruiting, 42 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 179 completed trials in Hospital for Special Surgery, 1 suspended trials, and 44 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital for Special Surgery, 11 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 49 trials, and there were also 115 trials that are defined as “Not Applicable".

Hospital for Special Surgery has several departments that took part in Clinical trials: "Hospital for Special Surgery, New York: Division of Rheumatology" - 3 trials